Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

NCT: NCT04864145 · RECRUITING

NCT IDNCT04864145
StatusRECRUITING
Start Date2021-05-21
Completion2031-05-30

Brief Summary

Prospective, multicenter, randomized trial.

Frequently Asked Questions

What is Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation?

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation is a clinical trial registered under NCT04864145. Current status: RECRUITING.

What is the status of NCT04864145?

The current status of NCT04864145 (Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation) is: RECRUITING.

When did Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation start?

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation started on 2021-05-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑